✉ Email this page to a colleague
« Back to Dashboard
Nitrendipine is an investigational drug.
There have been 9 clinical trials for Nitrendipine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Systolic Murmurs, and Neoplasm Metastasis. The leading clinical trial sponsors are Merck KGaA, Merck KGaA, Darmstadt, Germany, and Katholieke Universiteit Leuven.
Recent Clinical Trials for Nitrendipine
|The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.||Shanghai Jiao Tong University School of Medicine||Phase 4|
|Coronavirus (COVID-19) ACEi/ARB Investigation||National University of Ireland, Galway, Ireland||Phase 4|
|Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor||Alphacait, LLC||Phase 2|